Kala Bio

(NASDAQ) KALA

Current Price$2.25

Market Cap$44.43M

Since IPO (2017)-100%

5 Year-100%

1 Year-99%

1 Month-56%

Kala Bio Financials at a Glance

Market Cap

$44.43M

Revenue (TTM)

$0.00

Net Income (TTM)

-$19.65M

EPS (TTM)

-$138.24

P/E Ratio

-0.02

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$2.25

Volume

1,655

Open

$2.41

Price

$2.25

Volume

1,655

Open

$2.41

Previous Close

$2.25

Daily Range

$2.22 - $2.42

52-Week Range

$2.10 - $1,030.00

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$2.25

Volume

1,655

Open

$2.41

Previous Close

$2.25

Daily Range

$2.22 - $2.42

52-Week Range

$2.10 - $1,030.00

KALA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kala Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Avi Minkowitz

Website

www.kalarx.com

Headquarters

Arlington, MA 02476, US

KALA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-239%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$44.43M

Shares Outstanding

18.59M

Volume

1.66K

Avg. Volume

170.92K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$39.16M

EBITDA

-$23.39M

Operating Cash Flow

-$31.99M

Capital Expenditure

-$15.00K

Free Cash Flow

-$31.99M

Cash & ST Invst.

$7.56M

Total Debt

$0.00

Kala Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$44.43M

N/A

Market Cap/Employee

$1.17M

N/A

Employees

N/A

Net Income

-$1.62M

+81.9%

EBITDA

-$1.80M

+76.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$8.76M

-11.2%

Accounts Receivable

$74.00K

-97.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.60%

N/A

Return on Invested Capital

-2.82%

N/A

Free Cash Flow

-$2.90M

+67.2%

Operating Cash Flow

-$2.90M

+67.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VYNEVYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.$0.66-2.96%

XTLBXTL Biopharmaceuticals Ltd.

XTLBXTL Biopharmaceuticals Ltd.$2.26-1.31%

SNGXSoligenix, Inc.

SNGXSoligenix, Inc.$0.48-35.48%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.64-1.05%

ENSCEnsysce Biosciences, Inc.

ENSCEnsysce Biosciences, Inc.$0.27+1.30%

ABPAbpro Corporation

ABPAbpro Corporation$0.52+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$16.73-0.01%

INTCIntel

INTCIntel$112.71+0.04%

MRVLMarvell Technology

MRVLMarvell Technology$301.65+0.04%

NVTSNavitas Semiconductor

NVTSNavitas Semiconductor$30.84+0.19%

NUNu Holdings

NUNu Holdings$11.64-0.02%

XOSXos

XOSXos$7.46+2.35%

BBBlackBerry

BBBlackBerry$10.18-0.01%

Questions About KALA

What is the current price of Kala Bio?

Kala Bio is trading at $2.25 per share.

What is the 52-week range for Kala Bio?

Over the past 52 weeks, Kala Bio has traded between $2.10 and $1,030.00.

How much debt does Kala Bio have?

As of the most recent reporting period, Kala Bio reported total debt of $0.00.

How much cash does Kala Bio have on hand?

Kala Bio reported $1.76M in cash and cash equivalents in its most recent financial results.

What is Kala Bio’s dividend yield?

Kala Bio does not currently have a dividend yield.

Kala Bio

Kala Bio Financials at a Glance

KALA News

Kala Bio (KALA) Q2 Loss Widens 15%

Why Kala Pharmaceuticals Stock Sank Today

Keep Your Eye on These 4 Healthcare Stocks

How Medical Billing Coverage Spells Success Or Failure For Drugmakers

Kala Pharmaceuticals Reports Disappointing Q2 Sales

Here's Why Kala Pharmaceuticals Fell as Much as 17.7% Today

Here's Why Kala Pharmaceuticals Got Crushed on Friday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Kala Bio

KALA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Kala Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KALA

What is the current price of Kala Bio?

What is the 52-week range for Kala Bio?

How much debt does Kala Bio have?

How much cash does Kala Bio have on hand?

What is Kala Bio’s dividend yield?

Premium Investing Services